Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radioiodine treatment and dental caries in differentiated thyroid carcinoma survivors
NL-OMON50290Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Feb 2014
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Beta-minus Emitters → Radiopharmaceuticals, Gamma Emitters → Radiopharmaceuticals
- Countries
- 1
01
Overview
Open-label, single-arm trial of iodine-131 in well-differentiated thyroid cancer (WDTC), sponsored by University Medical Center Groningen. Primary endpoint: Difference in incident caries rate before versus after radioiodine therapy. Started Feb 2014; status: active, not recruiting.
02
Drugs
iodine-131
03
Conditions
well-differentiated thyroid cancer (WDTC)
Beyond the preview
Go deeper on NL-OMON50290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON50290.